Fragment‐Based Screen against HIV Protease
Authors:
Open Access
- 25 January 2010
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 75 (3) , 257-268
Abstract
We have employed a fragment‐based screen against wild‐type (NL4‐3) HIV protease (PR) using the Active Sight fragment library and X‐ray crystallography. The experiments reveal two new binding sites for small molecules. PR was co‐crystallized with fragments, or crystals were soaked in fragment solutions, using five crystal forms, and 378 data sets were collected to 2.3–1.3 Å resolution. Fragment binding induces a distinct conformation and specific crystal form of TL‐3 inhibited PR during co‐crystallization. One fragment, 2‐methylcyclohexanol, binds in the ‘exo site’ adjacent to the Gly 16 Gly 17 Gln 18 loop where the amide of Gly 17 is a specific hydrogen bond donor, and hydrophobic contacts occur with the side chains of Lys 14 and Leu 63 . Another fragment, indole‐6‐carboxylic acid, binds on the ‘outside/top of the flap’ via hydrophobic contacts with Trp 42 , Pro 44 , Met 46 , and Lys 55 , a hydrogen bond with Val 56 , and a salt‐bridge with Arg 57 . 2‐acetyl‐benzothiophene also binds at this site. This study is the first fragment‐based crystallographic screen against HIV PR, and the first time that fragments were screened against an inhibitor‐bound drug target to search for compounds that both bind to novel sites and stabilize the inhibited conformation of the target.Keywords
This publication has 55 references indexed in Scilit:
- Trapping Moving Targets with Small MoleculesScience, 2009
- Drug Pressure Selected Mutations in HIV-1 Protease Alter Flap ConformationsJournal of the American Chemical Society, 2008
- New paradigm for macromolecular crystallography experiments at SSRL: automated crystal screening and remote data collectionActa Crystallographica Section D Structural Biology, 2008
- Solution Structure of HIV-1 Protease Flaps Probed by Comparison of Molecular Dynamics Simulation Ensembles and EPR ExperimentsJournal of the American Chemical Society, 2008
- A poke in the eye: Inhibiting HIV‐1 protease through its flap‐recognition pocketBiopolymers, 2008
- Conformational flexibility in the flap domains of ligand-free HIV proteaseActa Crystallographica Section D Structural Biology, 2007
- Suppression of HIV-1 Protease Inhibitor Resistance by Phosphonate-mediated Solvent AnchoringJournal of Molecular Biology, 2006
- Anisotropic Dynamics of the JE-2147−HIV Protease Complex: Drug Resistance and Thermodynamic Binding Mode Examined in a 1.09 Å Structure,Biochemistry, 2002
- Refinement of Macromolecular Structures by the Maximum-Likelihood MethodActa Crystallographica Section D Structural Biology, 1997
- The CCP4 suite: programs for protein crystallographyActa Crystallographica Section D Structural Biology, 1994